It is associated with poor survival miR-551a directly targets GLIPR2 mRNA, which is a negative regulator of autophagy, and its overexpression leads to reduced GLIPR2 levels, thereby modulating autophagy and affecting the cancer cells’ response to treatment. This evidence concerns the gene GLIPR2 and cancer.